nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—sarcoma—acquired immunodeficiency syndrome	0.464	1	CtDrD
Mitoxantrone—SLC47A1—Ritonavir—acquired immunodeficiency syndrome	0.0718	0.187	CbGbCtD
Mitoxantrone—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0323	0.084	CbGbCtD
Mitoxantrone—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0279	0.0725	CbGbCtD
Mitoxantrone—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0245	0.0637	CbGbCtD
Mitoxantrone—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0245	0.0637	CbGbCtD
Mitoxantrone—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0182	0.0472	CbGbCtD
Mitoxantrone—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0181	0.0471	CbGbCtD
Mitoxantrone—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0164	0.0426	CbGbCtD
Mitoxantrone—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0426	CbGbCtD
Mitoxantrone—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0157	0.0408	CbGbCtD
Mitoxantrone—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0122	0.0316	CbGbCtD
Mitoxantrone—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0304	CbGbCtD
Mitoxantrone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00863	0.0224	CbGbCtD
Mitoxantrone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00781	0.0203	CbGbCtD
Mitoxantrone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00674	0.0175	CbGbCtD
Mitoxantrone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00654	0.017	CbGbCtD
Mitoxantrone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00592	0.0154	CbGbCtD
Mitoxantrone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00592	0.0154	CbGbCtD
Mitoxantrone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00567	0.0147	CbGbCtD
Mitoxantrone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0055	0.0143	CbGbCtD
Mitoxantrone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00517	0.0134	CbGbCtD
Mitoxantrone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00517	0.0134	CbGbCtD
Mitoxantrone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00468	0.0121	CbGbCtD
Mitoxantrone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00468	0.0121	CbGbCtD
Mitoxantrone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00439	0.0114	CbGbCtD
Mitoxantrone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00404	0.0105	CbGbCtD
Mitoxantrone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00392	0.0102	CbGbCtD
Mitoxantrone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00354	0.0092	CbGbCtD
Mitoxantrone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00354	0.0092	CbGbCtD
Mitoxantrone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0034	0.00882	CbGbCtD
Mitoxantrone—BTK—blood plasma—acquired immunodeficiency syndrome	0.00238	0.0664	CbGeAlD
Mitoxantrone—SLC47A2—digestive system—acquired immunodeficiency syndrome	0.00121	0.0339	CbGeAlD
Mitoxantrone—SLC47A2—vagina—acquired immunodeficiency syndrome	0.00107	0.0299	CbGeAlD
Mitoxantrone—PIM1—skin of body—acquired immunodeficiency syndrome	0.000991	0.0277	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—acquired immunodeficiency syndrome	0.000939	0.0262	CbGeAlD
Mitoxantrone—BTK—lymphoid tissue—acquired immunodeficiency syndrome	0.000926	0.0259	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—acquired immunodeficiency syndrome	0.000904	0.0252	CbGeAlD
Mitoxantrone—BTK—blood—acquired immunodeficiency syndrome	0.000872	0.0243	CbGeAlD
Mitoxantrone—BTK—bone marrow—acquired immunodeficiency syndrome	0.000844	0.0235	CbGeAlD
Mitoxantrone—BTK—spinal cord—acquired immunodeficiency syndrome	0.00084	0.0234	CbGeAlD
Mitoxantrone—BTK—vagina—acquired immunodeficiency syndrome	0.000808	0.0226	CbGeAlD
Mitoxantrone—PIM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000803	0.0224	CbGeAlD
Mitoxantrone—PIM1—digestive system—acquired immunodeficiency syndrome	0.000793	0.0221	CbGeAlD
Mitoxantrone—BTK—lung—acquired immunodeficiency syndrome	0.000764	0.0213	CbGeAlD
Mitoxantrone—PIM1—blood—acquired immunodeficiency syndrome	0.000755	0.0211	CbGeAlD
Mitoxantrone—PIM1—bone marrow—acquired immunodeficiency syndrome	0.000731	0.0204	CbGeAlD
Mitoxantrone—PIM1—spinal cord—acquired immunodeficiency syndrome	0.000728	0.0203	CbGeAlD
Mitoxantrone—SLC47A2—brain—acquired immunodeficiency syndrome	0.000717	0.02	CbGeAlD
Mitoxantrone—PIM1—vagina—acquired immunodeficiency syndrome	0.0007	0.0195	CbGeAlD
Mitoxantrone—PIM1—lung—acquired immunodeficiency syndrome	0.000662	0.0185	CbGeAlD
Mitoxantrone—PIM1—nervous system—acquired immunodeficiency syndrome	0.000613	0.0171	CbGeAlD
Mitoxantrone—PIM1—central nervous system—acquired immunodeficiency syndrome	0.00059	0.0165	CbGeAlD
Mitoxantrone—BTK—brain—acquired immunodeficiency syndrome	0.000541	0.0151	CbGeAlD
Mitoxantrone—BTK—lymph node—acquired immunodeficiency syndrome	0.000523	0.0146	CbGeAlD
Mitoxantrone—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000522	0.0146	CbGeAlD
Mitoxantrone—PIM1—brain—acquired immunodeficiency syndrome	0.000469	0.0131	CbGeAlD
Mitoxantrone—PIM1—lymph node—acquired immunodeficiency syndrome	0.000453	0.0126	CbGeAlD
Mitoxantrone—TOP2A—blood—acquired immunodeficiency syndrome	0.000443	0.0124	CbGeAlD
Mitoxantrone—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.000429	0.012	CbGeAlD
Mitoxantrone—SLC47A1—digestive system—acquired immunodeficiency syndrome	0.000425	0.0119	CbGeAlD
Mitoxantrone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00042	0.0117	CbGeAlD
Mitoxantrone—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.000418	0.271	CbGdCrCtD
Mitoxantrone—TOP2A—vagina—acquired immunodeficiency syndrome	0.000411	0.0115	CbGeAlD
Mitoxantrone—SLC47A1—blood—acquired immunodeficiency syndrome	0.000405	0.0113	CbGeAlD
Mitoxantrone—SLC47A1—spinal cord—acquired immunodeficiency syndrome	0.00039	0.0109	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000389	0.0109	CbGeAlD
Mitoxantrone—TOP2A—lung—acquired immunodeficiency syndrome	0.000388	0.0108	CbGeAlD
Mitoxantrone—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000382	0.248	CbGdCrCtD
Mitoxantrone—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000382	0.248	CbGdCrCtD
Mitoxantrone—SLC47A1—vagina—acquired immunodeficiency syndrome	0.000375	0.0105	CbGeAlD
Mitoxantrone—SLC47A1—lung—acquired immunodeficiency syndrome	0.000355	0.0099	CbGeAlD
Mitoxantrone—SLC47A1—nervous system—acquired immunodeficiency syndrome	0.000328	0.00917	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—acquired immunodeficiency syndrome	0.000316	0.00883	CbGeAlD
Mitoxantrone—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000315	0.0088	CbGeAlD
Mitoxantrone—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000311	0.00869	CbGeAlD
Mitoxantrone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000297	0.0083	CbGeAlD
Mitoxantrone—CYP1B1—blood—acquired immunodeficiency syndrome	0.000297	0.00828	CbGeAlD
Mitoxantrone—ABCC1—blood—acquired immunodeficiency syndrome	0.000267	0.00745	CbGeAlD
Mitoxantrone—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000266	0.00741	CbGeAlD
Mitoxantrone—CYP1B1—lung—acquired immunodeficiency syndrome	0.00026	0.00726	CbGeAlD
Mitoxantrone—SLC47A1—brain—acquired immunodeficiency syndrome	0.000251	0.00701	CbGeAlD
Mitoxantrone—ABCC1—vagina—acquired immunodeficiency syndrome	0.000247	0.0069	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—acquired immunodeficiency syndrome	0.000243	0.00677	CbGeAlD
Mitoxantrone—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000241	0.00672	CbGeAlD
Mitoxantrone—ABCC1—lung—acquired immunodeficiency syndrome	0.000234	0.00653	CbGeAlD
Mitoxantrone—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000232	0.00647	CbGeAlD
Mitoxantrone—ABCG2—blood—acquired immunodeficiency syndrome	0.000221	0.00616	CbGeAlD
Mitoxantrone—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000214	0.00596	CbGeAlD
Mitoxantrone—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000213	0.00594	CbGeAlD
Mitoxantrone—ABCG2—vagina—acquired immunodeficiency syndrome	0.000205	0.00571	CbGeAlD
Mitoxantrone—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000203	0.00567	CbGeAlD
Mitoxantrone—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000201	0.0056	CbGeAlD
Mitoxantrone—ABCG2—lung—acquired immunodeficiency syndrome	0.000194	0.0054	CbGeAlD
Mitoxantrone—CYP2E1—blood—acquired immunodeficiency syndrome	0.000191	0.00534	CbGeAlD
Mitoxantrone—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.122	CbGdCrCtD
Mitoxantrone—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000184	0.00514	CbGeAlD
Mitoxantrone—CYP1B1—brain—acquired immunodeficiency syndrome	0.000184	0.00514	CbGeAlD
Mitoxantrone—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000178	0.00496	CbGeAlD
Mitoxantrone—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.112	CbGdCrCtD
Mitoxantrone—CYP2E1—lung—acquired immunodeficiency syndrome	0.000168	0.00468	CbGeAlD
Mitoxantrone—ABCC1—brain—acquired immunodeficiency syndrome	0.000166	0.00462	CbGeAlD
Mitoxantrone—ABCB1—retina—acquired immunodeficiency syndrome	0.000163	0.00454	CbGeAlD
Mitoxantrone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000161	0.00451	CbGeAlD
Mitoxantrone—ABCC1—lymph node—acquired immunodeficiency syndrome	0.00016	0.00446	CbGeAlD
Mitoxantrone—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000155	0.00433	CbGeAlD
Mitoxantrone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000154	0.00429	CbGeAlD
Mitoxantrone—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00417	CbGeAlD
Mitoxantrone—ABCG2—brain—acquired immunodeficiency syndrome	0.000137	0.00382	CbGeAlD
Mitoxantrone—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000132	0.0037	CbGeAlD
Mitoxantrone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000125	0.00349	CbGeAlD
Mitoxantrone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00012	0.00336	CbGeAlD
Mitoxantrone—CYP2E1—brain—acquired immunodeficiency syndrome	0.000119	0.00331	CbGeAlD
Mitoxantrone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000116	0.00323	CbGeAlD
Mitoxantrone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000114	0.00319	CbGeAlD
Mitoxantrone—ABCB1—blood—acquired immunodeficiency syndrome	0.000109	0.00304	CbGeAlD
Mitoxantrone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000105	0.00294	CbGeAlD
Mitoxantrone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000105	0.00293	CbGeAlD
Mitoxantrone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000101	0.00282	CbGeAlD
Mitoxantrone—ABCB1—lung—acquired immunodeficiency syndrome	9.55e-05	0.00266	CbGeAlD
Mitoxantrone—ABCB1—nervous system—acquired immunodeficiency syndrome	8.84e-05	0.00247	CbGeAlD
Mitoxantrone—ABCB1—central nervous system—acquired immunodeficiency syndrome	8.51e-05	0.00238	CbGeAlD
Mitoxantrone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	7.85e-05	0.000691	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	7.84e-05	0.00069	CcSEcCtD
Mitoxantrone—Confusional state—Delavirdine—acquired immunodeficiency syndrome	7.82e-05	0.000689	CcSEcCtD
Mitoxantrone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	7.82e-05	0.000689	CcSEcCtD
Mitoxantrone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000689	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	7.82e-05	0.000689	CcSEcCtD
Mitoxantrone—Back pain—Lamivudine—acquired immunodeficiency syndrome	7.81e-05	0.000688	CcSEcCtD
Mitoxantrone—Vomiting—Didanosine—acquired immunodeficiency syndrome	7.77e-05	0.000685	CcSEcCtD
Mitoxantrone—Oedema—Delavirdine—acquired immunodeficiency syndrome	7.76e-05	0.000683	CcSEcCtD
Mitoxantrone—Anorexia—Efavirenz—acquired immunodeficiency syndrome	7.73e-05	0.000681	CcSEcCtD
Mitoxantrone—Rash—Didanosine—acquired immunodeficiency syndrome	7.71e-05	0.000679	CcSEcCtD
Mitoxantrone—Infection—Delavirdine—acquired immunodeficiency syndrome	7.71e-05	0.000679	CcSEcCtD
Mitoxantrone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	7.71e-05	0.000679	CcSEcCtD
Mitoxantrone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	7.71e-05	0.000679	CcSEcCtD
Mitoxantrone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	7.7e-05	0.000678	CcSEcCtD
Mitoxantrone—Cough—Ritonavir—acquired immunodeficiency syndrome	7.67e-05	0.000676	CcSEcCtD
Mitoxantrone—Headache—Didanosine—acquired immunodeficiency syndrome	7.66e-05	0.000675	CcSEcCtD
Mitoxantrone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	7.65e-05	0.000674	CcSEcCtD
Mitoxantrone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	7.64e-05	0.000673	CcSEcCtD
Mitoxantrone—Shock—Delavirdine—acquired immunodeficiency syndrome	7.63e-05	0.000672	CcSEcCtD
Mitoxantrone—Malaise—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000672	CcSEcCtD
Mitoxantrone—Somnolence—Indinavir—acquired immunodeficiency syndrome	7.63e-05	0.000672	CcSEcCtD
Mitoxantrone—Asthenia—Stavudine—acquired immunodeficiency syndrome	7.62e-05	0.000671	CcSEcCtD
Mitoxantrone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	7.62e-05	0.000671	CcSEcCtD
Mitoxantrone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	7.6e-05	0.00067	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	7.6e-05	0.000669	CcSEcCtD
Mitoxantrone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	7.59e-05	0.000668	CcSEcCtD
Mitoxantrone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	7.57e-05	0.000667	CcSEcCtD
Mitoxantrone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	7.57e-05	0.000667	CcSEcCtD
Mitoxantrone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	7.55e-05	0.000665	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	7.55e-05	0.000665	CcSEcCtD
Mitoxantrone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	7.54e-05	0.000664	CcSEcCtD
Mitoxantrone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	7.52e-05	0.000663	CcSEcCtD
Mitoxantrone—Asthenia—Abacavir—acquired immunodeficiency syndrome	7.5e-05	0.000661	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	7.5e-05	0.000661	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	7.49e-05	0.00066	CcSEcCtD
Mitoxantrone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	7.48e-05	0.000659	CcSEcCtD
Mitoxantrone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	7.48e-05	0.000659	CcSEcCtD
Mitoxantrone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	7.48e-05	0.000659	CcSEcCtD
Mitoxantrone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.46e-05	0.000657	CcSEcCtD
Mitoxantrone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	7.46e-05	0.000657	CcSEcCtD
Mitoxantrone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.000657	CcSEcCtD
Mitoxantrone—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.4e-05	0.000652	CcSEcCtD
Mitoxantrone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.39e-05	0.000651	CcSEcCtD
Mitoxantrone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.39e-05	0.000651	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.39e-05	0.000651	CcSEcCtD
Mitoxantrone—Cough—Saquinavir—acquired immunodeficiency syndrome	7.38e-05	0.00065	CcSEcCtD
Mitoxantrone—Pain—Indinavir—acquired immunodeficiency syndrome	7.34e-05	0.000646	CcSEcCtD
Mitoxantrone—Constipation—Indinavir—acquired immunodeficiency syndrome	7.34e-05	0.000646	CcSEcCtD
Mitoxantrone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.33e-05	0.000646	CcSEcCtD
Mitoxantrone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.000646	CcSEcCtD
Mitoxantrone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.3e-05	0.000643	CcSEcCtD
Mitoxantrone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.29e-05	0.000642	CcSEcCtD
Mitoxantrone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.29e-05	0.000642	CcSEcCtD
Mitoxantrone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.29e-05	0.000642	CcSEcCtD
Mitoxantrone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.28e-05	0.000641	CcSEcCtD
Mitoxantrone—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000641	CcSEcCtD
Mitoxantrone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.26e-05	0.00064	CcSEcCtD
Mitoxantrone—Nausea—Didanosine—acquired immunodeficiency syndrome	7.26e-05	0.00064	CcSEcCtD
Mitoxantrone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.25e-05	0.000638	CcSEcCtD
Mitoxantrone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.23e-05	0.000637	CcSEcCtD
Mitoxantrone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.23e-05	0.000637	CcSEcCtD
Mitoxantrone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.22e-05	0.000636	CcSEcCtD
Mitoxantrone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.21e-05	0.000635	CcSEcCtD
Mitoxantrone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.2e-05	0.000634	CcSEcCtD
Mitoxantrone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.2e-05	0.000634	CcSEcCtD
Mitoxantrone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.2e-05	0.000634	CcSEcCtD
Mitoxantrone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000632	CcSEcCtD
Mitoxantrone—Oedema—Ritonavir—acquired immunodeficiency syndrome	7.17e-05	0.000632	CcSEcCtD
Mitoxantrone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.16e-05	0.00063	CcSEcCtD
Mitoxantrone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.14e-05	0.000629	CcSEcCtD
Mitoxantrone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.12e-05	0.000627	CcSEcCtD
Mitoxantrone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.07e-05	0.000623	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.07e-05	0.000622	CcSEcCtD
Mitoxantrone—Shock—Ritonavir—acquired immunodeficiency syndrome	7.06e-05	0.000622	CcSEcCtD
Mitoxantrone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.05e-05	0.000621	CcSEcCtD
Mitoxantrone—Cough—Lamivudine—acquired immunodeficiency syndrome	7.04e-05	0.00062	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.02e-05	0.000619	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.02e-05	0.000618	CcSEcCtD
Mitoxantrone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7e-05	0.000617	CcSEcCtD
Mitoxantrone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.99e-05	0.000616	CcSEcCtD
Mitoxantrone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.99e-05	0.000616	CcSEcCtD
Mitoxantrone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.99e-05	0.000616	CcSEcCtD
Mitoxantrone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.97e-05	0.000614	CcSEcCtD
Mitoxantrone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.97e-05	0.000614	CcSEcCtD
Mitoxantrone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.96e-05	0.000613	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.000611	CcSEcCtD
Mitoxantrone—Pain—Efavirenz—acquired immunodeficiency syndrome	6.93e-05	0.000611	CcSEcCtD
Mitoxantrone—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.93e-05	0.000611	CcSEcCtD
Mitoxantrone—Rash—Nevirapine—acquired immunodeficiency syndrome	6.93e-05	0.000611	CcSEcCtD
Mitoxantrone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.93e-05	0.00061	CcSEcCtD
Mitoxantrone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.92e-05	0.000609	CcSEcCtD
Mitoxantrone—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.9e-05	0.000608	CcSEcCtD
Mitoxantrone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.9e-05	0.000607	CcSEcCtD
Mitoxantrone—Headache—Nevirapine—acquired immunodeficiency syndrome	6.89e-05	0.000607	CcSEcCtD
Mitoxantrone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000605	CcSEcCtD
Mitoxantrone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000605	CcSEcCtD
Mitoxantrone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000605	CcSEcCtD
Mitoxantrone—Infection—Saquinavir—acquired immunodeficiency syndrome	6.86e-05	0.000604	CcSEcCtD
Mitoxantrone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000603	CcSEcCtD
Mitoxantrone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000602	CcSEcCtD
Mitoxantrone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.83e-05	0.000601	CcSEcCtD
Mitoxantrone—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.82e-05	0.0006	CcSEcCtD
Mitoxantrone—Shock—Saquinavir—acquired immunodeficiency syndrome	6.79e-05	0.000598	CcSEcCtD
Mitoxantrone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.79e-05	0.000598	CcSEcCtD
Mitoxantrone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.78e-05	0.000597	CcSEcCtD
Mitoxantrone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.78e-05	0.000597	CcSEcCtD
Mitoxantrone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.77e-05	0.000596	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.76e-05	0.000595	CcSEcCtD
Mitoxantrone—ABCB1—brain—acquired immunodeficiency syndrome	6.76e-05	0.00189	CbGeAlD
Mitoxantrone—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.75e-05	0.000595	CcSEcCtD
Mitoxantrone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.74e-05	0.000594	CcSEcCtD
Mitoxantrone—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.71e-05	0.000591	CcSEcCtD
Mitoxantrone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.71e-05	0.000591	CcSEcCtD
Mitoxantrone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.71e-05	0.000591	CcSEcCtD
Mitoxantrone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.7e-05	0.00059	CcSEcCtD
Mitoxantrone—Rash—Stavudine—acquired immunodeficiency syndrome	6.69e-05	0.00059	CcSEcCtD
Mitoxantrone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.69e-05	0.000589	CcSEcCtD
Mitoxantrone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.69e-05	0.000589	CcSEcCtD
Mitoxantrone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.68e-05	0.000588	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000588	CcSEcCtD
Mitoxantrone—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.67e-05	0.000588	CcSEcCtD
Mitoxantrone—Headache—Stavudine—acquired immunodeficiency syndrome	6.65e-05	0.000586	CcSEcCtD
Mitoxantrone—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.65e-05	0.000586	CcSEcCtD
Mitoxantrone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.64e-05	0.000585	CcSEcCtD
Mitoxantrone—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.63e-05	0.000584	CcSEcCtD
Mitoxantrone—Pain—Delavirdine—acquired immunodeficiency syndrome	6.63e-05	0.000584	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.63e-05	0.000584	CcSEcCtD
Mitoxantrone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.62e-05	0.000583	CcSEcCtD
Mitoxantrone—Rash—Abacavir—acquired immunodeficiency syndrome	6.59e-05	0.000581	CcSEcCtD
Mitoxantrone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.59e-05	0.00058	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.00058	CcSEcCtD
Mitoxantrone—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.00058	CcSEcCtD
Mitoxantrone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.58e-05	0.00058	CcSEcCtD
Mitoxantrone—Headache—Abacavir—acquired immunodeficiency syndrome	6.55e-05	0.000577	CcSEcCtD
Mitoxantrone—Infection—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000576	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.54e-05	0.000576	CcSEcCtD
Mitoxantrone—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.53e-05	0.000575	CcSEcCtD
Mitoxantrone—ABCB1—lymph node—acquired immunodeficiency syndrome	6.53e-05	0.00182	CbGeAlD
Mitoxantrone—Shock—Lamivudine—acquired immunodeficiency syndrome	6.48e-05	0.000571	CcSEcCtD
Mitoxantrone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.45e-05	0.000568	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.45e-05	0.000568	CcSEcCtD
Mitoxantrone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.44e-05	0.000567	CcSEcCtD
Mitoxantrone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.44e-05	0.000567	CcSEcCtD
Mitoxantrone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.41e-05	0.000565	CcSEcCtD
Mitoxantrone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.41e-05	0.000565	CcSEcCtD
Mitoxantrone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000564	CcSEcCtD
Mitoxantrone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.000563	CcSEcCtD
Mitoxantrone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.39e-05	0.000563	CcSEcCtD
Mitoxantrone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.38e-05	0.000562	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.000561	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000559	CcSEcCtD
Mitoxantrone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.33e-05	0.000557	CcSEcCtD
Mitoxantrone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.32e-05	0.000557	CcSEcCtD
Mitoxantrone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.31e-05	0.000556	CcSEcCtD
Mitoxantrone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.31e-05	0.000556	CcSEcCtD
Mitoxantrone—Nausea—Stavudine—acquired immunodeficiency syndrome	6.31e-05	0.000555	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000554	CcSEcCtD
Mitoxantrone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000553	CcSEcCtD
Mitoxantrone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.24e-05	0.000549	CcSEcCtD
Mitoxantrone—Nausea—Abacavir—acquired immunodeficiency syndrome	6.21e-05	0.000547	CcSEcCtD
Mitoxantrone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.2e-05	0.000546	CcSEcCtD
Mitoxantrone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.18e-05	0.000545	CcSEcCtD
Mitoxantrone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.16e-05	0.000543	CcSEcCtD
Mitoxantrone—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.16e-05	0.000542	CcSEcCtD
Mitoxantrone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.16e-05	0.000542	CcSEcCtD
Mitoxantrone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.16e-05	0.000542	CcSEcCtD
Mitoxantrone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.14e-05	0.000541	CcSEcCtD
Mitoxantrone—Pain—Ritonavir—acquired immunodeficiency syndrome	6.13e-05	0.00054	CcSEcCtD
Mitoxantrone—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.13e-05	0.00054	CcSEcCtD
Mitoxantrone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.00054	CcSEcCtD
Mitoxantrone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.00054	CcSEcCtD
Mitoxantrone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.08e-05	0.000535	CcSEcCtD
Mitoxantrone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6e-05	0.000529	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6e-05	0.000529	CcSEcCtD
Mitoxantrone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.97e-05	0.000526	CcSEcCtD
Mitoxantrone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.95e-05	0.000524	CcSEcCtD
Mitoxantrone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000521	CcSEcCtD
Mitoxantrone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.91e-05	0.000521	CcSEcCtD
Mitoxantrone—Pain—Saquinavir—acquired immunodeficiency syndrome	5.9e-05	0.00052	CcSEcCtD
Mitoxantrone—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.9e-05	0.00052	CcSEcCtD
Mitoxantrone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000517	CcSEcCtD
Mitoxantrone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.87e-05	0.000517	CcSEcCtD
Mitoxantrone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.87e-05	0.000517	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.87e-05	0.000517	CcSEcCtD
Mitoxantrone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000516	CcSEcCtD
Mitoxantrone—Rash—Zidovudine—acquired immunodeficiency syndrome	5.82e-05	0.000512	CcSEcCtD
Mitoxantrone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.82e-05	0.000512	CcSEcCtD
Mitoxantrone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.81e-05	0.000512	CcSEcCtD
Mitoxantrone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.8e-05	0.000511	CcSEcCtD
Mitoxantrone—Headache—Zidovudine—acquired immunodeficiency syndrome	5.78e-05	0.000509	CcSEcCtD
Mitoxantrone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.73e-05	0.000504	CcSEcCtD
Mitoxantrone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.72e-05	0.000503	CcSEcCtD
Mitoxantrone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.7e-05	0.000502	CcSEcCtD
Mitoxantrone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.69e-05	0.000501	CcSEcCtD
Mitoxantrone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.68e-05	0.0005	CcSEcCtD
Mitoxantrone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.000499	CcSEcCtD
Mitoxantrone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.000499	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.65e-05	0.000497	CcSEcCtD
Mitoxantrone—Pain—Lamivudine—acquired immunodeficiency syndrome	5.63e-05	0.000496	CcSEcCtD
Mitoxantrone—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.63e-05	0.000496	CcSEcCtD
Mitoxantrone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.57e-05	0.00049	CcSEcCtD
Mitoxantrone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.55e-05	0.000489	CcSEcCtD
Mitoxantrone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.49e-05	0.000483	CcSEcCtD
Mitoxantrone—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.48e-05	0.000483	CcSEcCtD
Mitoxantrone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000481	CcSEcCtD
Mitoxantrone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000481	CcSEcCtD
Mitoxantrone—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.46e-05	0.000481	CcSEcCtD
Mitoxantrone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.43e-05	0.000478	CcSEcCtD
Mitoxantrone—Rash—Indinavir—acquired immunodeficiency syndrome	5.41e-05	0.000477	CcSEcCtD
Mitoxantrone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.41e-05	0.000476	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000474	CcSEcCtD
Mitoxantrone—Headache—Indinavir—acquired immunodeficiency syndrome	5.38e-05	0.000473	CcSEcCtD
Mitoxantrone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.31e-05	0.000467	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.29e-05	0.000466	CcSEcCtD
Mitoxantrone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.23e-05	0.000461	CcSEcCtD
Mitoxantrone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000459	CcSEcCtD
Mitoxantrone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000459	CcSEcCtD
Mitoxantrone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.16e-05	0.000454	CcSEcCtD
Mitoxantrone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.15e-05	0.000453	CcSEcCtD
Mitoxantrone—Rash—Efavirenz—acquired immunodeficiency syndrome	5.11e-05	0.00045	CcSEcCtD
Mitoxantrone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.11e-05	0.00045	CcSEcCtD
Mitoxantrone—Nausea—Indinavir—acquired immunodeficiency syndrome	5.1e-05	0.000449	CcSEcCtD
Mitoxantrone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.000448	CcSEcCtD
Mitoxantrone—Headache—Efavirenz—acquired immunodeficiency syndrome	5.08e-05	0.000447	CcSEcCtD
Mitoxantrone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.95e-05	0.000436	CcSEcCtD
Mitoxantrone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.93e-05	0.000434	CcSEcCtD
Mitoxantrone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.91e-05	0.000432	CcSEcCtD
Mitoxantrone—Rash—Delavirdine—acquired immunodeficiency syndrome	4.89e-05	0.000431	CcSEcCtD
Mitoxantrone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.89e-05	0.00043	CcSEcCtD
Mitoxantrone—Headache—Delavirdine—acquired immunodeficiency syndrome	4.86e-05	0.000428	CcSEcCtD
Mitoxantrone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.85e-05	0.000427	CcSEcCtD
Mitoxantrone—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.82e-05	0.000424	CcSEcCtD
Mitoxantrone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.000416	CcSEcCtD
Mitoxantrone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.72e-05	0.000416	CcSEcCtD
Mitoxantrone—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.61e-05	0.000406	CcSEcCtD
Mitoxantrone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.56e-05	0.000402	CcSEcCtD
Mitoxantrone—Rash—Ritonavir—acquired immunodeficiency syndrome	4.52e-05	0.000398	CcSEcCtD
Mitoxantrone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.52e-05	0.000398	CcSEcCtD
Mitoxantrone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.51e-05	0.000397	CcSEcCtD
Mitoxantrone—Headache—Ritonavir—acquired immunodeficiency syndrome	4.49e-05	0.000396	CcSEcCtD
Mitoxantrone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.39e-05	0.000387	CcSEcCtD
Mitoxantrone—Rash—Saquinavir—acquired immunodeficiency syndrome	4.35e-05	0.000383	CcSEcCtD
Mitoxantrone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.35e-05	0.000383	CcSEcCtD
Mitoxantrone—Headache—Saquinavir—acquired immunodeficiency syndrome	4.33e-05	0.000381	CcSEcCtD
Mitoxantrone—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.26e-05	0.000375	CcSEcCtD
Mitoxantrone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.19e-05	0.000369	CcSEcCtD
Mitoxantrone—Rash—Lamivudine—acquired immunodeficiency syndrome	4.15e-05	0.000366	CcSEcCtD
Mitoxantrone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.15e-05	0.000365	CcSEcCtD
Mitoxantrone—Headache—Lamivudine—acquired immunodeficiency syndrome	4.13e-05	0.000363	CcSEcCtD
Mitoxantrone—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.1e-05	0.000361	CcSEcCtD
Mitoxantrone—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.91e-05	0.000345	CcSEcCtD
